A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: development (514), fruition (7), growth (369), progress (323), progression (277), advancement (15)

Two duties of candour

Description
In the summer of 2015, the views of the Department of Health (DH), the Nursing and Midwifery Council (NMC) and the
Url
/HealthProfessionals/Clinical-law-updates/Twodutiesofcandour.aspx

Papers Trust Board - 13 May 2025

Description
Agenda Trust Board – Open Session Date Time Location Chair Apologies In attendance 13/05/2025 9:00 - 13:00 Conference Room
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-13-May-2025.pdf

Bevacizumab ver 1

Description
Chemotherapy Protocol CNS CANCER BEVACIZUMAB This protocol may require funding. This is an unlicensed indication for bevacizumab. Regimen
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Bevacizumab-ver-1.pdf

Bevacizumab (15mgkg)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15) This protocol may require funding Regimen Ovary-Bevacizumab (15) Indication R
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg.pdf

Bevacizumab(15mgkg) Carboplatin Gemcitabine (day1)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1) This protocol may require funding Regi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg-Carboplatin-Gemcitabine-day1.pdf

Bevacizumab (15) Carboplatin-Paclitaxel (21 day)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Cervix-Bevacizumab (15)-Carb
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/Bevacizumab-15-Carboplatin-Paclitaxel-21-day.pdf

Bevacizumab-Irinotecan Ver 1.1

Description
Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-IRINOTECAN This protocol may require funding Regimen Colorectal Cancer – Bevacizumab-I
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-IrinotecanVer11.pdf

Bevacizumab-Fluorouracil-Folinic Acid-Oxaliplatin

Description
Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)OXALIPLATIN This regimen may require fu
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Fluorouracil-FolinicAcid-Oxaliplatin.pdf

Bevacizumab-Fluorouracil-Folinic Acid-Irinotecan

Description
Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN This regimen may require fun
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Fluorouracil-FolinicAcid-Irinotecan.pdf

Bevacizumab-Capecitabine

Description
Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-CAPECITABINE This protocol may require funding Regimen • Colorectal Cancer– Bevacizuma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Capecitabine.pdf
1 to 10 of 20
Previous 1 2 Next